Skip to content
DraconiticResearch
Search Sources API
210,089 studies31 sourcesUpdated 8 min ago

Oncology

5,305 studies560 in 7 days2,549 in 30 days

Filters
Type
Date
Clear

Latest

5,305 studies

  1. Emergency Colorectal Cancer During COVID-19: A Retrospective Cohort Study of Temporal Trends in Presentation, Tumour Characteristics, and Management in a Regional Australian Health Service.
    Olivia McNeil, Marcio B Coehlo, Zachary Woodward +1
    CureusPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  2. Genomic classification and immune profiling define mucosal melanoma
    Y. Shi, P. Sharma, J.-r. Lin +20
    bioRxivPreprintCC BYFull textOncologybioRxiv
  3. HMGA2 Expression in Pancreatic Ductal Adenocarcinoma Controls Tumor Microenvironment and Immunosuppression via IL1α
    N. Yamamoto, S. Dobersch, T. M. Robertson +20
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  4. RBFOX2 restrains oncogenic cell plasticity in Group 3 medulloblastoma
    R. K. Sah, X. Yan, L. Louis +14
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  5. CRISPR-Cas9 Editing of Myeloid Lectins Reveals Target-Dependent Transcriptional Remodeling in Tumor-Associated Macrophages
    G. Trindade, M. Pinto, G. Domenici +2
    bioRxivPreprintCC BYFull textOncologybioRxiv
  6. Revisiting AXL as a therapeutic target in soft tissue sarcoma: dubermatinib and bemcentinib effects are largely independent of AXL inhibition
    C. Garnes-Garcia, P. Fernandez-Aroca, F. J. Cimas +7
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  7. KSHV upregulates the long non-coding RNA PURPL via p73 to suppress p53
    S. Showgan, D. Meary, G. Journo +2
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  8. Spatial transcriptomics reveals tumour cell-intrinsic and microenvironmental features associated with survival in high-grade serous ovarian carcinoma
    M. A. A. K. Khan, W. Lin, E. Denisenko +7
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  9. Matched primary-metastasis single-nucleus and spatial profiling of leiomyosarcoma identifies antigen-presenting fibroblasts at the tumor-organ interface
    A. Kuebler, L. Bergmayr, T. Knoesel +20
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  10. A Dual-Stream Feature Learning Framework with Adaptive Bio-Inspired Protozoa-Starfish Optimization for Melanoma Classification.
    Sreelakshmi Jayasankar, Thomas Brindha
    Biomimetics (Basel, Switzerland)Peer-reviewedCC BYFull textOncologyEurope PMC
  11. Pathological Response Depth and Pre-Treatment Risk Stratification After Neoadjuvant Chemoradiotherapy for Rectal Cancer.
    Tibiana Negru, Loredana Gabriela Stana, Livia Stanga +3
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textOncologyEurope PMCDOAJ
  12. Proteomic Profiling of Immune Cell Infiltration Reveals Prognostic Immune Subtypes in Lung Adenocarcinoma.
    Ruoxian Zhang, Hongsheng Guo, Xianju Li +2
    ProteomesPeer-reviewedCC BYFull textOncologyEurope PMC
  13. Dermatopathology 2030: Navigating the Digital, Computational and Molecular Convergence for Precision Diagnostics-Originated from a Round Table Discussion at A 66, Basel.
    Carlo Tomasini, Maria-Teresa Fernández-Figueras, Gürkan Kaya
    Dermatopathology (Basel, Switzerland)Peer-reviewedCC BYFull textOncologyEurope PMC
  14. Imaging evolution of pancreatic intraductal oncocytic papillary neoplasm presenting with recurrent pancreatitis: A case report and literature review.
    Ying Liu, Hao Yu, Lianjun Zhou +1
    Experimental and therapeutic medicinePeer-reviewedCC BYFull textOncologyEurope PMC
  15. Non-invasive detection of mutagenic exposure to aristolochic acid using ultra-deep sequencing of blood and urine samples
    P. T. Nguyen, A. Boot, P.-H. Lin +12
    medRxivPreprintCC BYFull textOncologymedRxiv
  16. Integrated single-cell and proteomic profiling of pancreatic neoplasia identifies tissue markers that outperform established diagnostic markers in distinguishing cancer from precursor lesions.
    T. T. Tran, P. U. Nguyen Hoang, D. T. Pham +4
    medRxivPreprintCC BYFull textOncologymedRxiv
  17. Sanguinarine Induces Pyroptosis via the Hippo Signaling Pathway and Remodels the Tumor Immune Microenvironment in Lung Adenocarcinoma.
    Jia Yang, Lanfang Li, Yunjian Pan +11
    International journal of biological sciencesPeer-reviewedCC BYFull textOncologyEurope PMC
  18. Predictive markers of response and toxicity to tarlatamab in patients with extensive stage small cell lung cancer: a multi-institutional real-world analysis
    G. Fenton, W. Guo, D. L. Hess +11
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  19. Spatial distribution and age-specific geodemographic patterns of Acute Lymphoblastic Leukemia (ALL) mortality in Ecuador: an ecological analysis across elevation gradients (2011–2022)
    Xavier García-León, Esteban Fernández-Moreira, Manuel Gómez del Moral +3
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0OncologyCrossref
  20. Anti–PD-1 Therapy and Long-Term Toxic Effects Among Patients With Melanoma
    Roma A. Kankaria, Reilly Fankhauser, Andrea Boutros +14
    JAMA Network OpenPeer-reviewedCC BY 4.01 citedOncologyCrossref
  21. Epstein-Barr virus-associated T/NK-cell lymphoproliferative diseases with heterozygous IL10RA variants: two cases with pedigree analysis and a literature review.
    Yixin Yan, Ge Song, Liang Huang +3
    Global medical geneticsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  22. Same-Day Coordination of Mohs Surgery, Lymphoscintigraphy, and Sentinel Lymph Node Biopsy for Merkel Cell Carcinoma: A Single-Center Feasibility Report.
    Victoria H Ruesch, Justin Thrush, James F Bena +10
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  23. Sleep Impairment in Oncology: Development of a Novel Patient-Centric Conceptual Model.
    Harriet Makin, Sophie Van Tomme, Natalie V J Aldhouse +5
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  24. Presentation Delay After Symptom Recognition Among Breast Cancer Patients in Mongolia: A Retrospective Study.
    Bolormaa Dalkhjav, Avirmed Damdin, Naranchimeg Sodovsuren +1
    Healthcare (Basel, Switzerland)Peer-reviewedCC BYFull textOncologyEurope PMC
  25. Developing a Dual-Targeting CD33/CD70 CAR T-Cell Strategy Against Acute Myeloid Leukemia to Overcome Tumor Heterogeneity.
    Emily C Sullivan, Nabil Saleem, Areeba A Hashmi +5
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref